MedTrace Logo

Tight Glycemic Control by Artificial Pancreas

NCT00657995 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2008-04-14

No results posted yet for this study

Summary

This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.

Conditions

  • Pancreatic Neoplasm

Interventions

DEVICE

Artificial Pancreas (STG-22)

safe tool

Sponsors & Collaborators

  • Kochi University

    lead OTHER

Principal Investigators

  • Takehiro Okabayashi, MD · Kochi Medical School, Kochi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-12-31
Completion
2007-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00657995 on ClinicalTrials.gov